Literature DB >> 17502523

Reduced ocular allergy with fixed-combination 0.2% brimonidine-0.5% timolol.

Jorge A Alvarado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17502523     DOI： 10.1001/archopht.125.5.717-a

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  4 in total

1.  Brimonidine-timolol fixed combination induced granulomatous inflammation of the eye.

Authors:  María Alejandra Carrasco; Bernardo Ariel Schlaen; Jorge Oscar Zárate
Journal:  Int Ophthalmol       Date:  2012-12-06       Impact factor: 2.031

2.  Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension.

Authors:  Anna Galanopoulos; Ivan Goldberg
Journal:  Clin Ophthalmol       Date:  2009-06-02

3.  Preliminary results following the use of a fixed combination of timolol-brimonidine in patients with ocular hypertension and primary open-angle glaucoma.

Authors:  Dimitris Papaconstantinou; Ilias Georgalas; Nikolaos Kourtis; Christos Pitsas; Efthimios Karmiris; Chrysanthi Koutsandrea; Ioannis Ladas; Gerasimos Georgopoulos
Journal:  Clin Ophthalmol       Date:  2009-06-02

4.  Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2008-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.